In the age of COVID, diagnostics have become more valuable than ever.  EDP Biotech has been fortunate to advance diagnostic programs in colorectal cancer and COVID testing during the last year, and our company has been selected as finalists in the upcoming MedCity INVEST Pitch Perfect event!
This annual event is the premier national healthcare investing conference, allowing EDP to showcase our advancements in cancer detection and clinical testing in front of top healthcare firms including Cleveland Clinic Ventures.
Read more about this exciting healthcare event below, and Register to attend the virtual sessions at the MedCity News main page!